A1c & glucose: the early-warning numbers that lifestyle moves first

Most of the diseases that shorten a modern lifespan announce themselves late. Metabolic disease is the exception — it leaves fingerprints in the blood for years before it earns a diagnosis, and two ordinary, inexpensive tests can read them. That early-warning quality is the whole reason A1c and fasting glucose sit in the cardiometabolic tier rather than buried in a specialist’s panel. They aren’t a treatment; they’re the numbers that tell you whether you need to act while acting still works easily.

HbA1c is a three-month average of your blood sugar, measured by how much glucose has stuck to your red blood cells — so a single high-carb meal or a stressful morning can’t distort it. Fasting glucose is a single snapshot taken after an overnight fast. They measure different things and can disagree with each other, which is a feature, not a bug: either one drifting upward is worth paying attention to.

What the numbers mean

The American Diabetes Association draws the lines clearly:

• Normal: A1c below 5.7%, or fasting glucose below 100 mg/dL.
• Prediabetes: A1c 5.7–6.4%, or fasting glucose 100–125 mg/dL.
• Diabetes: A1c 6.5% or higher, or fasting glucose 126 mg/dL or higher (confirmed).

The prediabetes band is the point of this entry. It is not a mild version of a distant problem — it’s the window in which the trajectory is easiest to change, and it is extremely common. A large share of adults sit in it without knowing, because there are usually no symptoms at all. The number is doing the work the body isn’t yet complaining about.

What the evidence shows

Here’s the part that makes measuring worthwhile: early metabolic dysfunction is not a one-way street. The Diabetes Prevention Program (DPP) — a large, randomized trial in adults with prediabetes — remains one of the cleanest demonstrations in all of prevention. It compared an intensive lifestyle program (modest weight loss and about 150 minutes a week of activity) against metformin against placebo. Over roughly three years, the lifestyle group cut its progression to type 2 diabetes by 58%, and the metformin group by 31%.

Read that comparison carefully, because it’s unusual. At this stage, the lifestyle intervention outperformed the drug. That’s the evidence base behind a genuinely hopeful message: for many people, a rising A1c is a signal to move — literally — not a sentence, and the foundations (training, protein, sleep, body composition) are the most effective tool available.

When medication enters

Lifestyle-first does not mean lifestyle-only forever. Metformin has a real role, and guidelines specifically consider it for higher-risk people with prediabetes — younger adults, those with higher A1c, those with a history of gestational diabetes. And once numbers cross into diabetes, or when lifestyle change isn’t enough to hold the line, medication becomes appropriate and, sometimes, essential. The point isn’t to avoid drugs on principle; it’s that at the prediabetes stage you have leverage that a later stage doesn’t offer.

The honest bottom line: A1c and fasting glucose are among the highest-value cheap tests you can run. Prediabetes is common, usually silent, and — per the DPP — often reversible, with lifestyle change beating medication at this stage. The verdict is simple: know these numbers, and if they’re drifting, treat that as an early invitation to act rather than a problem for later.